Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
5.06
+1.11 (28.10%)
At close: Sep 4, 2025, 4:00 PM
5.09
+0.03 (0.59%)
After-hours: Sep 4, 2025, 7:58 PM EDT

Aquestive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
61232513549156180
Upgrade
Market Cap Growth
38.90%140.67%176.07%-68.73%-13.14%-3.55%
Upgrade
Enterprise Value
59228415585169229
Upgrade
Last Close Price
5.063.562.020.903.895.35
Upgrade
PS Ratio
10.815.642.671.023.073.92
Upgrade
PB Ratio
--5.40-1.27-0.41-1.90-3.71
Upgrade
EV/Sales Ratio
13.414.933.061.793.324.99
Upgrade
Debt / Equity Ratio
-0.56-0.63-0.31-0.48-0.69-0.83
Upgrade
Asset Turnover
0.420.730.880.800.810.65
Upgrade
Inventory Turnover
2.282.793.323.954.614.87
Upgrade
Quick Ratio
3.134.181.770.811.831.84
Upgrade
Current Ratio
3.534.682.241.012.152.12
Upgrade
Return on Assets (ROA)
-31.12%-24.21%-16.49%-44.16%-34.71%-37.93%
Upgrade
Return on Capital (ROIC)
------116.06%
Upgrade
Earnings Yield
-10.63%-13.60%-5.83%-111.37%-45.15%-31.01%
Upgrade
FCF Yield
-8.17%-11.07%-5.47%-22.20%-21.69%-25.56%
Upgrade
Buyback Yield / Dilution
-27.20%-41.58%-25.69%-27.99%-13.15%-32.71%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q